BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

679 related articles for article (PubMed ID: 15199091)

  • 21. Outcome after radical cystectomy in patients with clinical T2 bladder cancer in whom neoadjuvant chemotherapy has failed.
    Manoharan M; Katkoori D; Kishore TA; Kava B; Singal R; Soloway MS
    BJU Int; 2009 Dec; 104(11):1646-9. PubMed ID: 19466944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy.
    Shariat SF; Svatek RS; Tilki D; Skinner E; Karakiewicz PI; Capitanio U; Bastian PJ; Volkmer BG; Kassouf W; Novara G; Fritsche HM; Izawa JI; Ficarra V; Lerner SP; Sagalowsky AI; Schoenberg MP; Kamat AM; Dinney CP; Lotan Y; Marberger MJ; Fradet Y
    BJU Int; 2010 May; 105(10):1402-12. PubMed ID: 20132195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant cisplatin plus methotrexate versus methotrexate, vinblastine, epirubicin, and cisplatin in locally advanced bladder cancer: results of a randomized, multicenter, phase III trial (AUO-AB 05/95).
    Lehmann J; Retz M; Wiemers C; Beck J; Thüroff J; Weining C; Albers P; Frohneberg D; Becker T; Funke PJ; Walz P; Langbein S; Reiher F; Schiller M; Miller K; Roth S; Kälble T; Sternberg D; Wellek S; Stöckle M;
    J Clin Oncol; 2005 Aug; 23(22):4963-74. PubMed ID: 15939920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC.
    Kassouf W; Agarwal PK; Herr HW; Munsell MF; Spiess PE; Brown GA; Pisters L; Grossman HB; Dinney CP; Kamat AM
    J Clin Oncol; 2008 Jan; 26(1):121-6. PubMed ID: 18165646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of patients who refuse cystectomy after receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer.
    Herr HW
    Eur Urol; 2008 Jul; 54(1):126-32. PubMed ID: 18248875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guideline.
    Segal R; Winquist E; Lukka H; Chin JL; Brundage M; Markman BR;
    Can J Urol; 2002 Oct; 9(5):1625-33. PubMed ID: 12431323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome after radical cystectomy with limited or extended pelvic lymph node dissection.
    Dhar NB; Klein EA; Reuther AM; Thalmann GN; Madersbacher S; Studer UE
    J Urol; 2008 Mar; 179(3):873-8; discussion 878. PubMed ID: 18221953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy.
    Wright JL; Lin DW; Porter MP
    Cancer; 2008 Jun; 112(11):2401-8. PubMed ID: 18383515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for recurrence following radical cystectomy for pathologic node negative bladder cancer.
    Hugen CM; Polcari AJ; Fitzgerald MP; Dauw C; Flanigan RC; Quek ML
    J Surg Oncol; 2010 Sep; 102(4):334-7. PubMed ID: 20607757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph node positivity and density.
    Wiesner C; Salzer A; Thomas C; Gellermann-Schultes C; Gillitzer R; Hampel C; Thüroff JW
    BJU Int; 2009 Aug; 104(3):331-5. PubMed ID: 19220265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: a combined analysis of two Nordic studies.
    Sherif A; Holmberg L; Rintala E; Mestad O; Nilsson J; Nilsson S; Malmström PU;
    Eur Urol; 2004 Mar; 45(3):297-303. PubMed ID: 15036674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Multivariate evaluation of survival factors and postoperative adjuvant chemotherapy in patients with bladder cancer treated by radical cystectomy].
    Takashi M; Murase T; Aota Y; Nagai T; Kinjo T; Sabashi M; Shimoji T; Miyake K; Hamajma N; Mizuno S
    Hinyokika Kiyo; 1988 Aug; 34(8):1377-81. PubMed ID: 2461643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer.
    Stein JP; Penson DF; Lee C; Cai J; Miranda G; Skinner DG
    J Urol; 2009 May; 181(5):2052-8; discussion 2058-9. PubMed ID: 19286213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program.
    Konety BR; Joslyn SA
    J Urol; 2003 Nov; 170(5):1765-71. PubMed ID: 14532772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer.
    Rosenblatt R; Sherif A; Rintala E; Wahlqvist R; Ullén A; Nilsson S; Malmström PU;
    Eur Urol; 2012 Jun; 61(6):1229-38. PubMed ID: 22189383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laparoscopic radical cystectomy for cancer: oncological outcomes at up to 5 years.
    Haber GP; Gill IS
    BJU Int; 2007 Jul; 100(1):137-42. PubMed ID: 17552961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy.
    Park J; Park S; Song C; Doo C; Cho YM; Ahn H; Kim CS
    Urology; 2007 Aug; 70(2):257-62. PubMed ID: 17826485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
    Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
    BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plenary debate of randomized phase III trial of neoadjuvant MVAC plus cystectomy versus cystectomy alone in patients with locally advanced bladder cancer.
    Bajorin DF
    J Clin Oncol; 2001 Sep; 19(18 Suppl):17S-20S. PubMed ID: 11560966
    [No Abstract]   [Full Text] [Related]  

  • 40. Timing cystectomy and perioperative chemotherapy in the treatment of muscle invasive bladder cancer.
    Izawa JI; Chin JL; Winquist E
    Can J Urol; 2006 Jun; 13 Suppl 3():48-53. PubMed ID: 16818012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.